|
|
|
|
||
|
||
|
Vol. 7, Nos. 1-43, pp. 1-1268 Jan. 2 -- Oct. 30, 2009 # | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Natco Pharma Ltd.; Shire PLC v. (S.D.N.Y.), 405
National Ass'n of Chain Drug Stores v. HHS (D.D.C.), 228; 765 National Ass'n of Chain Drug Stores v. New England Carpenters Health Benefits Fund (1st Cir.), 1022; 1082 National Ass'n of Chain Drug Stores v. Schwarzenegger (C.D. Cal.), 1165 Navinta LLC; Abraxis Bioscience Inc. v. (D.N.J.), 907; 1035 Neal v. Eli Lilly and Co. (E.D.N.Y.), 768 Neurontin Antitrust Litig., In re (D.N.J.), 1026 Neurontin Mktg., Sales Practices and Prods. Liab. Litig., In re (D. Mass.), 556; 612 New England Carpenters Health Benefits Fund v. First Databank Inc. (D. Mass.), 307; 500; 909; (1st Cir.), 553 New England Carpenters Health Benefits Fund; National Ass'n of Chain Drug Stores v. (1st Cir.), 1022; 1082 New Mexico v. AstraZeneca Pharms. LP (D.N.M.), 852 Nifedipine Antitrust Litig., In re (D.C. Cir.), 229 Novartis Corp. v. Cobalt Labs. Inc. (D.N.J.), 13 Novartis Corp. v. Lupin Ltd. (D.N.J.), 1068 Novartis Corp. v. Par Pharm. Cos. (D.N.J.), 201 Novartis Pharms. Corp.; D'Anna v. (D.N.J.), 734 Novartis Pharms. Corp.; Frey v. (S.D. Ohio), 970 Novartis Pharms. Corp. v. Roxane Labs. Inc. (D.N.J.), 553 Novartis Pharms. Corp.; Stevens v. (Mont. Dist. Ct.), 1254 Novartis Pharms. Corp. v. Teva Pharms. USA Inc. (D.N.J.), 254 Novartis Wage & Hour Litig., In re (S.D.N.Y.), 121 Novo Nordisk A/S v. Caraco Pharm. Labs. Ltd. (E.D. Mich.), 733 Novo Nordisk A/S; SEC v. (D.D.C.), 558 Novo Nordisk A/S; U.S. v. (D.D.C.), 558 NuvaRing Prods. Liab. Litig., In re (E.D. Mo.), 367 Nuvelo Inc. Sec. Litig., In re (N.D. Cal.), 12 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |
